FEIM vs. LAB, ALNT, EYPT, AEHR, QTRX, QSI, NAUT, KEQU, RPID, and SEER
Should you be buying Frequency Electronics stock or one of its competitors? The main competitors of Frequency Electronics include Standard BioTools (LAB), Allient (ALNT), EyePoint Pharmaceuticals (EYPT), Aehr Test Systems (AEHR), Quanterix (QTRX), Quantum-Si (QSI), Nautilus Biotechnology (NAUT), Kewaunee Scientific (KEQU), Rapid Micro Biosystems (RPID), and Seer (SEER). These companies are all part of the "measuring and control equipment" industry.
Frequency Electronics vs.
Frequency Electronics (NASDAQ:FEIM) and Standard BioTools (NASDAQ:LAB) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability, community ranking, risk and media sentiment.
58.6% of Frequency Electronics shares are held by institutional investors. Comparatively, 53.7% of Standard BioTools shares are held by institutional investors. 26.1% of Frequency Electronics shares are held by insiders. Comparatively, 53.1% of Standard BioTools shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Frequency Electronics received 81 more outperform votes than Standard BioTools when rated by MarketBeat users. However, 100.00% of users gave Standard BioTools an outperform vote while only 60.14% of users gave Frequency Electronics an outperform vote.
Frequency Electronics has higher earnings, but lower revenue than Standard BioTools. Standard BioTools is trading at a lower price-to-earnings ratio than Frequency Electronics, indicating that it is currently the more affordable of the two stocks.
In the previous week, Standard BioTools had 1 more articles in the media than Frequency Electronics. MarketBeat recorded 2 mentions for Standard BioTools and 1 mentions for Frequency Electronics. Frequency Electronics' average media sentiment score of 1.93 beat Standard BioTools' score of 0.00 indicating that Frequency Electronics is being referred to more favorably in the media.
Frequency Electronics has a beta of 0.39, indicating that its share price is 61% less volatile than the S&P 500. Comparatively, Standard BioTools has a beta of 1.57, indicating that its share price is 57% more volatile than the S&P 500.
Frequency Electronics has a net margin of 13.02% compared to Standard BioTools' net margin of -79.92%. Frequency Electronics' return on equity of 21.49% beat Standard BioTools' return on equity.
Standard BioTools has a consensus price target of $2.88, indicating a potential upside of 121.15%. Given Standard BioTools' stronger consensus rating and higher probable upside, analysts plainly believe Standard BioTools is more favorable than Frequency Electronics.
Summary
Frequency Electronics and Standard BioTools tied by winning 9 of the 18 factors compared between the two stocks.
Get Frequency Electronics News Delivered to You Automatically
Sign up to receive the latest news and ratings for FEIM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Frequency Electronics Competitors List
Related Companies and Tools
This page (NASDAQ:FEIM) was last updated on 2/22/2025 by MarketBeat.com Staff
